Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINCom: Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome
NCT07473635Recruiting
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in complex regional pain syndrome (CRPS). Primary endpoints: Recruitment rate at Day 84, Screening-to-enrolment ratio at Day 84 and 2 more. Started Jan 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT07473635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07473635.